Search research articles
Contact Us
Filters
Showing results (171-180 of 221) with videos related to
Page
of 23
Sort By:
International Journal of STD & AIDS
|
August 30, 2012
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience
L Waters, B Patterson, A Scourfield, et al.
Antiviral Research
|
December 2, 1998
Summary of the II International Symposium on Cytomegalovirus
M D de Jong, G J Galasso, B Gazzard, et al.
Clinical and Experimental Immunology
|
October 30, 1999
Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
N Imami, G A Hardy, M R Nelson, et al.
Clinical Pharmacology and Therapeutics
|
September 28, 2007
Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects
K Singh, L Dickinson, A Chaikan, et al.
AIDS (London, England)
|
August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA
N Clumeck, F Goebel, W Rozenbaum, et al.
Lancet (London, England)
|
July 20, 1991
Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex
G Pialoux, M Youle, B Dupont, et al.
Clinical and Experimental Immunology
|
August 4, 2007
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease
S A Clark, S L Martin, A Pozniak, et al.
Journal of Neurovirology
|
December 28, 2017
CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study
T J Barber, A Imaz, M Boffito, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1990
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex
A Karpas, I K Hewlett, F Hill, et al.
Journal of Neurovirology
|
January 11, 2018
Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study
T J Barber, A Imaz, M Boffito, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 221) with videos related to
Sort By:
Page
of 23
International Journal of STD & AIDS
|
August 30, 2012
A dedicated clinic for HIV-positive individuals over 50 years of age: a multidisciplinary experience
L Waters, B Patterson, A Scourfield, et al.
Antiviral Research
|
December 2, 1998
Summary of the II International Symposium on Cytomegalovirus
M D de Jong, G J Galasso, B Gazzard, et al.
Clinical and Experimental Immunology
|
October 30, 1999
Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy
N Imami, G A Hardy, M R Nelson, et al.
Clinical Pharmacology and Therapeutics
|
September 28, 2007
Pharmacokinetics and safety of saquinavir/ritonavir and omeprazole in HIV-infected subjects
K Singh, L Dickinson, A Chaikan, et al.
AIDS (London, England)
|
August 16, 2001
Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA
N Clumeck, F Goebel, W Rozenbaum, et al.
Lancet (London, England)
|
July 20, 1991
Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex
G Pialoux, M Youle, B Dupont, et al.
Clinical and Experimental Immunology
|
August 4, 2007
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease
S A Clark, S L Martin, A Pozniak, et al.
Journal of Neurovirology
|
December 28, 2017
CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study
T J Barber, A Imaz, M Boffito, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1990
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex
A Karpas, I K Hewlett, F Hill, et al.
Journal of Neurovirology
|
January 11, 2018
Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study
T J Barber, A Imaz, M Boffito, et al.
Page
of 23